Ars Pharmaceuticals, Inc. (($SPRY)) announced an update on their ongoing clinical study. Study Overview: Ars Pharmaceuticals, Inc. is conducting a ...
TipRanks on MSN
Nasus Pharma’s Innovative Approach to Anaphylaxis Treatment: A Clinical Study Update
Nasus Pharma Ltd. (($NSRX)) announced an update on their ongoing clinical study. Study Overview: Nasus Pharma Ltd. is conducting a clinical study ...
The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback